Lv11
72 积分 2024-03-29 加入
Harnessing cytokines and chemokines for cancer therapy
4小时前
已完结
Interleukins in cancer: from biology to therapy
4小时前
已完结
A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy
8天前
已完结
An agonist TIGIT mab suppresses regulatory T cell activity via an IL-2-mediated mechanism
12天前
已关闭
Abstract 5520: AK129, an anti-PD1/LAG-3 bi-specific antibody for cancer therapy
29天前
已关闭
The response to anti–PD-1 and anti–LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming
30天前
已完结
LAG-3 as the third checkpoint inhibitor
1个月前
已完结
Understanding LAG3 immune checkpoint function
1个月前
已完结
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells
1个月前
已完结
Lung tumor–infiltrating Treghave divergent transcriptional profiles and function linked to checkpoint blockade response
1个月前
已完结
皖公网安备34019202002308
